Agilent Technologies (NYSE:A) Shares Gap Up After Better-Than-Expected Earnings

Key Points

• Agilent Technologies shares jumped after the company reported better-than-expected quarterly results, opening at $133.00 versus the prior close of $115.84. The stock was last up about 16% in premarket trading.
• The company beat estimates with adjusted EPS of $1.49 versus $1.41 expected and revenue of about $1.84 billion versus $1.80 billion forecast, with sales rising 10% year over year.
• Agilent also raised its full-year 2026 guidance and issued upbeat Q3 outlook, while analyst sentiment remained positive with new buy/outperform ratings and higher price targets.

Agilent Technologies, Inc. (NYSE:A - Get Free Report) shares gapped up before the market opened on Thursday following a stronger than expected earnings report. The stock had previously closed at $115.84, but opened at $133.00. Agilent Technologies shares last traded at $133.0660, with a volume of 1,257,004 shares changing hands.

The medical research company reported $1.49 EPS for the quarter, beating analysts' consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.84 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the prior year, the business earned $1.31 earnings per share. The firm's revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies's dividend payout ratio (DPR) is currently 22.52%.

Key Headlines Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent beat Wall Street’s Q2 expectations, reporting adjusted EPS of $1.49 versus estimates around $1.41 and revenue of $1.83 billion, above forecasts, with revenue up 10% year over year. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its full-year 2026 profit outlook and also issued Q3 guidance that points to continued growth, reinforcing confidence in demand for its lab tools and diagnostic products. Agilent raises 2026 profit forecast on strong demand for lab tools
• Positive Sentiment: Bank of America upgraded Agilent from neutral to buy, which typically helps sentiment because it signals improved confidence in the stock’s upside. Benzinga report on Bank of America upgrade
• Positive Sentiment: RBC also initiated coverage with an outperform rating and a $153 price target, adding another bullish analyst call after earnings. Benzinga report on RBC coverage
• Neutral Sentiment: Agilent also highlighted new product launches and digital-lab tools, including OpenLab Sync and new GC systems, which support the longer-term growth story but are less likely to move the stock immediately. Agilent Introduces OpenLab Sync

Analysts Set New Price Targets

A number of research analysts recently commented on A shares. Robert W. Baird upped their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a research note on Tuesday. Wells Fargo & Company lowered their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an "overweight" rating on the stock in a report on Thursday, February 26th. UBS Group reduced their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a report on Thursday, February 26th. Royal Bank Of Canada assumed coverage on shares of Agilent Technologies in a research report on Wednesday. They set an "outperform" rating and a $153.00 target price on the stock. Finally, Bank of America raised shares of Agilent Technologies from a "neutral" rating to a "buy" rating and lowered their target price for the company from $150.00 to $145.00 in a research note on Thursday. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Buy" and an average target price of $161.07.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Bridgefront Capital LLC bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $1,323,000. Wellington Management Group LLP boosted its stake in Agilent Technologies by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company's stock worth $1,203,990,000 after acquiring an additional 433,342 shares during the last quarter. Envestnet Asset Management Inc. grew its holdings in Agilent Technologies by 3.8% during the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company's stock valued at $78,026,000 after purchasing an additional 22,498 shares during the period. Generation Investment Management LLP grew its holdings in Agilent Technologies by 10.1% during the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company's stock valued at $816,043,000 after purchasing an additional 582,093 shares during the period. Finally, Champlain Investment Partners LLC increased its stake in Agilent Technologies by 33.3% in the third quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company's stock valued at $114,972,000 after purchasing an additional 223,750 shares in the last quarter.

Agilent Technologies Trading Up 16.1%

The company's fifty day simple moving average is $114.99 and its two-hundred day simple moving average is $128.79. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $38.01 billion, a price-to-earnings ratio of 29.73, a price-to-earnings-growth ratio of 2.42 and a beta of 1.22.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.